Peter Besmer

Medicine · Health Sciences

67h-index20.1kcitations176works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Gastrointestinal Tumor Research and Treatment(69), Mast cells and histamine(31), Sarcoma Diagnosis and Treatment(30), Platelet Disorders and Treatments(21), Virus-based gene therapy research(19)

Publications176 total

Table S2 from Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
2023Open Access
Supplementary table 1 from Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
2023Open Access
Supplementary Figure Legends from Combined Inhibition of MAP Kinase and KIT Signaling Synergistically Destabilizes ETV1 and Suppresses GIST Tumor Growth
2023Open Access
Data from Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
2023Open Access
Data from Combined Inhibition of MAP Kinase and KIT Signaling Synergistically Destabilizes ETV1 and Suppresses GIST Tumor Growth
2023Open Access
Data from Combined Inhibition of MAP Kinase and KIT Signaling Synergistically Destabilizes ETV1 and Suppresses GIST Tumor Growth
2023Open Access
Figure S1 from Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
2023Open Access
Figure S1 from Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
2023Open Access
Figure S4 from Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
2023Open Access
Supplementary table 1 from Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
2023Open Access
Supplementary Table 2 from Combined Inhibition of MAP Kinase and KIT Signaling Synergistically Destabilizes ETV1 and Suppresses GIST Tumor Growth
2023Open Access
Figure S4 from Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
2023Open Access
Figure S2 from Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
2023Open Access
Supplementary Figure Legends from Combined Inhibition of MAP Kinase and KIT Signaling Synergistically Destabilizes ETV1 and Suppresses GIST Tumor Growth
2023Open Access
Supplementary Table 1 from Combined Inhibition of MAP Kinase and KIT Signaling Synergistically Destabilizes ETV1 and Suppresses GIST Tumor Growth
2023Open Access
Figure S5 from Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
2023Open Access
Supplementary Table 3 from Combined Inhibition of MAP Kinase and KIT Signaling Synergistically Destabilizes ETV1 and Suppresses GIST Tumor Growth
2023Open Access
Supplementary Table 2 from Combined Inhibition of MAP Kinase and KIT Signaling Synergistically Destabilizes ETV1 and Suppresses GIST Tumor Growth
2023Open Access
Supplementary Table 1 from Combined Inhibition of MAP Kinase and KIT Signaling Synergistically Destabilizes ETV1 and Suppresses GIST Tumor Growth
2023Open Access
Figure S3 from Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor
2023Open Access
page 1 of 9Next →

Frequent Co-authors

Cristina R. Antonescu(16), Ronald P. DeMatteo(12), Robert G. Maki(9), Tianhua Guo(7), Rosemary F. Bachvarova(7), Eric J. Huang(6), Samuel Singer(5), K Nocka(5), Narasimhan P. Agaram(5), Grace C. Wong(5), Katia Manova(5), Murray F. Brennan(4), Ferdinand Rossi(4), Lisa Sarran(4), Alan Packer(4), Nicholas D. Socci(4), Nelson S. Yee(4), Karl Nocka(3), Tang‐Yuan Chu(3), Jochen Buck(3)